You're Avoiding Gluten and Still Getting Sick. Here's Why.

HLA-DQ2 is a specialized receptor on the surface of your immune cells that presents antigens (protein fragments) to your T cells, essentially showing them what to attack. In the case of gluten, HLA-DQ2 is particularly good at capturing gluten peptides and holding them up to your immune system in a way that screams “threat.” This is the first domino in the celiac cascade. Without HLA-DQ2 (or HLA-DQ8), celiac disease cannot develop. It’s that foundational.

Approximately 25-30% of people with European ancestry carry the HLA-DQ2.5 haplotype (DQA1*05 + DQB1*02). If you have HLA-DQ2, your immune cells are genetically wired to recognize gluten peptides as dangerous. Every time you eat gluten, your DQ2 molecules grab those peptides and present them to your T cells in a way that triggers an adaptive immune response. This is not an allergy (which is IgE-mediated and immediate); it’s a true autoimmune cascade.

You experience this at the cellular level as intestinal inflammation. If you have DQ2 and eat gluten regularly, your immune system launches an attack on the lining of your small intestine. Over weeks and months, this flattens the villi (finger-like projections that absorb nutrients), leading to malabsorption, bloating, brain fog, and systemic symptoms. The damage isn’t random inflammation; it’s targeted destruction of the tissue that feeds you.

HLA-DQ8 (DQA1*03 + DQB1*03:02) is functionally similar to DQ2 but evolutionarily distinct. It also presents gluten peptides to your immune system, triggering the same cascade of attack on intestinal tissue. The difference is prevalence and ancestry. While DQ2 is found in roughly 25-30% of European populations, DQ8 is found in approximately 5-10% of European ancestry and is more common in some Mediterranean, Middle Eastern, and Latin American populations.

If you carry HLA-DQ8, you have a nearly identical gluten recognition system to someone with DQ2, just assembled from different HLA gene segments. About 95% of people with confirmed celiac disease carry either DQ2 or DQ8 (or both). Having DQ8 means you are genetically capable of mounting a celiac-like immune response to gluten. The rest of the system (your immune regulation genes, your gut barrier genes) will determine whether that capability becomes an actual disease.

You’ll experience the same intestinal damage as someone with DQ2: villi flattening, nutrient malabsorption, inflammation, and all the downstream symptoms. The molecular lock-and-key mechanism is the same. DQ8 is actually slightly more efficient at some gluten peptide presentations, which is why some DQ8-positive people report equally severe or even more severe symptoms than DQ2-positive individuals.

IL2 (interleukin-2) is a signaling molecule that amplifies T-cell activation. Think of it as the volume knob on your immune response. IL2 is released by helper T cells and acts as an autocrine and paracrine signal, telling other T cells to proliferate, differentiate, and sustain their attack. In the context of celiac disease, once your HLA-DQ2/DQ8 cells present gluten peptides to your T cells, IL2 is what transforms a single activated T cell into an army.

Roughly 30% of the population carry variants in IL2 or the related IL21 gene that amplify immune signaling in the gut. If you carry these variants and have HLA-DQ2 or DQ8, your adaptive immune response to gluten is not just triggered; it’s amplified. More T cells become activated. The response lasts longer. The bystander damage to surrounding tissue is greater. This is why some people with the same HLA genotype as their sibling have much more severe celiac disease; IL2 variants often segregate independently.

You feel this as more severe and longer-lasting intestinal inflammation. Your symptoms don’t just appear when you eat gluten; they cascade and amplify over hours and days. Your immune system is slower to stand down. Intestinal repair takes longer. This is also why some people with IL2 variants respond well to immune-modulating interventions (like vitamin D, curcumin, or omega-3 supplementation) that others don’t.

CTLA4 (cytotoxic T-lymphocyte-associated protein 4) is an inhibitory checkpoint molecule. It’s your immune system’s brake pedal. When T cells become activated and start attacking, CTLA4 is supposed to emerge on their surface and signal “enough, stand down.” This prevents autoimmunity from spiraling into complete tissue destruction. CTLA4 is so important that blocking it is actually a standard cancer treatment (ipilimumab is a monoclonal antibody against CTLA4 used in melanoma and other cancers). By removing the brake, you unleash the immune system to attack cancer cells, but you also increase autoimmunity risk.

Approximately 45% of the population carries the CTLA4 +49A>G variant that reduces checkpoint function. If you carry this variant and have HLA-DQ2/DQ8 plus IL2 amplification, your immune system not only recognizes gluten and amplifies the response; it also has defective brakes. The T cells that attack your intestines are less likely to receive a “stop” signal. The inflammatory cascade continues longer. More intestinal damage accumulates before the response finally resolves.

You experience this as symptoms that don’t resolve quickly, intestinal damage that doesn’t heal well even after going gluten-free, and a tendency toward other autoimmune conditions (thyroid, joint, skin). This is also why some people with celiac disease develop complications like dermatitis herpetiformis or refractory celiac disease; CTLA4 variants interact with the other five genes to determine severity and phenotype.

MTHFR (methylenetetrahydrofolate reductase) converts dietary folate and B12 into their active methylated forms: methylfolate and methylcobalamin. These are the substrates for methylation reactions throughout your body, but especially in your intestinal cells. Intestinal epithelial cells divide every 3-5 days and require constant methylation to produce DNA, repair damage, maintain tight junctions, and support immune tolerance. If MTHFR is slow, your intestinal cells cannot repair or replace themselves efficiently.

The MTHFR C677T variant, carried by roughly 40% of the population, reduces enzyme efficiency by 40-70%. If you have MTHFR C677T and celiac disease, your intestinal cells are fighting a gluten-induced immune attack while simultaneously lacking the methylation substrates they need to repair themselves. This creates a vicious cycle: gluten triggers immune attack, villi flatten, you go gluten-free, but your intestinal repair stalls because your MTHFR-variant cells cannot efficiently methylate the B vitamins in your diet.

You experience this as slow recovery after gluten exposure. You might go strictly gluten-free and still feel unwell for months, while others recover in weeks. You have persistent bloating, brain fog, and nutrient malabsorption even after the gluten is gone. You might also notice a tendency toward constipation, irregular motility, and poor overall energy because your gut barrier cannot fully restore itself.

TNF (tumor necrosis factor-alpha) is a pro-inflammatory cytokine that, among many roles, regulates intestinal permeability. In physiological amounts, TNF helps coordinate immune responses. At elevated levels, TNF tightens the intestinal epithelium to prevent bacterial translocation and to allow immune cells to access luminal antigens. But chronically elevated TNF also damages the tight junction proteins (claudins, occludin, ZO-1) that hold intestinal cells together, creating the “leaky gut” phenomenon.

The TNF -308G>A variant (rs1800629) is carried by roughly 30% of the population and is associated with elevated baseline TNF-alpha production. If you carry the TNF -308A allele and have celiac disease, your gut barrier is inherently more permeable, allowing partially digested food proteins and lipopolysaccharides from gram-negative bacteria to cross into your bloodstream. This triggers additional immune activation, increases intestinal inflammation, and prevents the gut barrier from healing even after you eliminate gluten.

You experience this as “leaky gut” symptoms: increased food sensitivities (even to non-gluten foods), broader intestinal inflammation, systemic immune activation (joint pain, skin reactions, brain fog), and slower recovery from accidental gluten exposure. You might also have worse reactions to alcohol, NSAIDs, or other intestinal irritants because your barrier is fundamentally more fragile.